This announcement details the progress of Xiamen Ad Biomed's share repurchase plan. As of May 31, 2026, the company repurchased 4,364,300 shares, representing 1.12% of the total share capital, for a total of 90,972,271.03 yuan. The repurchase aligns with the approved plan and regulatory requirements. The company will continue the repurchase within the specified period based on market conditions.
Summary generated by AI · Always verify with source document
Securities Code: 300685 Securities Abbreviation: Ad Biomed Announcement No.: 2026-036
Xiamen Ad Biomed Medical Technology Co., Ltd. Announcement on the Progress of Company Share Repurchase
The Company and all members of the Board of Directors guarantee the content of the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.